trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Cystadenocarcinoma, Mucinous D018282 1 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Papillary, Follicular D018265 1 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Rhabdomyosarcoma, Embryonal D018233 1 associated lipids
Rhabdomyosarcoma, Alveolar D018232 2 associated lipids
Fibromatosis, Aggressive D018222 2 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Rehni AK et al. Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome. 2012 Naunyn Schmiedebergs Arch. Pharmacol. pmid:22362134
Yin Z et al. Position effect variegation and epigenetic modification of a transgene in a pig model. 2012 Genet. Mol. Res. pmid:22370938
Halldórsdóttir AM et al. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia. 2012 Am. J. Hematol. pmid:22374828
Ikehata M et al. Different involvement of DNA methylation and histone deacetylation in the expression of solute-carrier transporters in 4 colon cancer cell lines. 2012 Biol. Pharm. Bull. pmid:22382314
Andrews KT et al. Comparative gene expression profiling of P. falciparum malaria parasites exposed to three different histone deacetylase inhibitors. 2012 PLoS ONE pmid:22384084
Zhu S et al. TSA-induced JMJD2B downregulation is associated with cyclin B1-dependent survivin degradation and apoptosis in LNCap cells. 2012 J. Cell. Biochem. pmid:22388778
Usui T et al. HDAC4 mediates development of hypertension via vascular inflammation in spontaneous hypertensive rats. 2012 Am. J. Physiol. Heart Circ. Physiol. pmid:22389387
Schnichels S et al. Trichostatin A induces cell death at the concentration recommended to differentiate the RGC-5 cell line. 2012 Neurochem. Int. pmid:22391323
Wang H et al. Different effects of histone deacetylase inhibitors nicotinamide and trichostatin A (TSA) in C17.2 neural stem cells. 2012 J Neural Transm pmid:22407380
Yang PM et al. CD1d induction in solid tumor cells by histone deacetylase inhibitors through inhibition of HDAC1/2 and activation of Sp1. 2012 Epigenetics pmid:22419072
Qin ZX et al. [Effect of TSA and VPA treatment on long-tailed macaque (Macaca fascicularis)-pig interspecies somatic cell nuclear transfer]. 2012 Yi Chuan pmid:22425953
Zhou X et al. Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells. 2012 Biochem. Biophys. Res. Commun. pmid:22425986
Bar-Nur O et al. Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives. 2012 J Mol Cell Biol pmid:22430918
Gou Z et al. Epigenetic modification of TLRs in leukocytes is associated with increased susceptibility to Salmonella enteritidis in chickens. 2012 PLoS ONE pmid:22438967
Huang D et al. A novel series of l-2-benzyloxycarbonylamino-8-(2-pyridyl)-disulfidyloctanoic acid derivatives as histone deacetylase inhibitors: design, synthesis and molecular modeling study. 2012 Eur J Med Chem pmid:22465091
Chuma M et al. Hairless modulates ligand-dependent activation of the vitamin D receptor-retinoid X receptor heterodimer. 2012 Biol. Pharm. Bull. pmid:22466564
Li J et al. Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. 2012 Nat. Med. pmid:22466704
Sangalli JR et al. Treatment of nuclear-donor cells or cloned zygotes with chromatin-modifying agents increases histone acetylation but does not improve full-term development of cloned cattle. 2012 Cell Reprogram pmid:22468998
Yamamura N and Kishimoto T Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma. 2012 Exp. Mol. Pathol. pmid:22472323
Zhang HN et al. Endogenous glucocorticoids inhibit myocardial inflammation induced by lipopolysaccharide: involvement of regulation of histone deacetylation. 2012 J. Cardiovasc. Pharmacol. pmid:22472906
Tu Z et al. The enhanced antiproliferative response to combined treatment of trichostatin A with raloxifene in MCF-7 breast cancer cells and its relevance to estrogen receptor β expression. 2012 Mol. Cell. Biochem. pmid:22476901
Halsall J et al. Genes are often sheltered from the global histone hyperacetylation induced by HDAC inhibitors. 2012 PLoS ONE pmid:22479401
Mehdi O et al. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA). 2012 Mar-Apr Pancreatology pmid:22487525
Ching LY et al. Synergistic effect of p53 on TSA-induced stanniocalcin 1 expression in human nasopharyngeal carcinoma cells, CNE2. 2012 J. Mol. Endocrinol. pmid:22493143
Fleiss B et al. Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury. 2012 J Neuroinflammation pmid:22512781
Eun CH et al. Activation and epigenetic regulation of DNA transposon nDart1 in rice. 2012 Plant Cell Physiol. pmid:22514089
Li Q and Chen H Silencing of Wnt5a during colon cancer metastasis involves histone modifications. 2012 Epigenetics pmid:22522911
Chawalit S et al. Trichostatin A and ascorbic acid assist in the development of porcine handmade cloned embryos via different physiologic pathways. 2012 Reprod Sci pmid:22534331
Reddy P Editorial: HDAC inhibition begets more MDSCs. 2012 J. Leukoc. Biol. pmid:22547132
Kang FW et al. Effects of trichostatin A on HIF-1α and VEGF expression in human tongue squamous cell carcinoma cells in vitro. 2012 Oncol. Rep. pmid:22552321
Meng J et al. The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways. 2012 Oncol. Rep. pmid:22552631
Hsieh TH et al. Phthalates stimulate the epithelial to mesenchymal transition through an HDAC6-dependent mechanism in human breast epithelial stem cells. 2012 Toxicol. Sci. pmid:22552774
Hou W et al. Hypoxia-induced deacetylation is required for tetraploid differentiation in response to testicular ischemia-reperfusion (IR) injury. 2012 Nov-Dec J. Androl. pmid:22556385
Cheng SP et al. Regulation of leptin receptor expression in human papillary thyroid cancer cells. 2012 Biomed. Pharmacother. pmid:22560341
He M and Guo Q [Cerebral protection of Trichostatin A preconditioning in rats with middle cerebral artery occlusion and the relationship between Trichostatin A and IL-1β]. 2012 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:22561570
Catalano MG et al. Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells. 2012 J. Clin. Endocrinol. Metab. pmid:22563106
Yu L et al. Trichostatin A ameliorates myocardial ischemia/reperfusion injury through inhibition of endoplasmic reticulum stress-induced apoptosis. 2012 Arch. Med. Res. pmid:22564421
Bobkov DE et al. [Isolation of tropomyosin particles from the cytosol of cultured cells and their protein composition analysis]. 2012 Tsitologiia pmid:22567898
Hizume K et al. Nano-scale analyses of the chromatin decompaction induced by histone acetylation. 2010 Arch. Histol. Cytol. pmid:22572182
Srirattana K et al. Full-term development of gaur-bovine interspecies somatic cell nuclear transfer embryos: effect of trichostatin A treatment. 2012 Cell Reprogram pmid:22578161
Park J et al. ARD1 binding to RIP1 mediates doxorubicin-induced NF-κB activation. 2012 Biochem. Biophys. Res. Commun. pmid:22580278
Truong M et al. Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence. 2012 Br. J. Cancer pmid:22596233
Hsu DW et al. Dynamic acetylation of lysine-4-trimethylated histone H3 and H3 variant biology in a simple multicellular eukaryote. 2012 Nucleic Acids Res. pmid:22600736
Dhawan D et al. DNMT1: an emerging target in the treatment of invasive urinary bladder cancer. 2013 Urol. Oncol. pmid:22609058
Viñuelas J et al. Towards experimental manipulation of stochasticity in gene expression. 2012 Prog. Biophys. Mol. Biol. pmid:22609563
Wu TC et al. Genistein enhances the effect of trichostatin A on inhibition of A549 cell growth by increasing expression of TNF receptor-1. 2012 Toxicol. Appl. Pharmacol. pmid:22626855
Kim YS et al. Histone deacetylase is required for the activation of Wnt/β-catenin signaling crucial for heart valve formation in zebrafish embryos. 2012 Biochem. Biophys. Res. Commun. pmid:22634317
Buurman R et al. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. 2012 Gastroenterology pmid:22641068
Orlova DY et al. Arrangement of nuclear structures is not transmitted through mitosis but is identical in sister cells. 2012 J. Cell. Biochem. pmid:22644811
Glait-Santar C et al. Expression pattern of SVEP1 alternatively-spliced forms. 2012 Gene pmid:22659106
Mitchell MD et al. Epigenetic regulation of cytokine production in human amnion and villous placenta. 2012 Mediators Inflamm. pmid:22665947
Kim Y et al. Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein. 2012 J. Biol. Chem. pmid:22679019
Royce SG et al. Effects of the histone deacetylase inhibitor, trichostatin A, in a chronic allergic airways disease model in mice. 2012 Arch. Immunol. Ther. Exp. (Warsz.) pmid:22684086
Jung N et al. Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma. 2012 J. Korean Med. Sci. pmid:22690089
Nunes MJ et al. Okadaic acid inhibits the trichostatin A-mediated increase of human CYP46A1 neuronal expression in a ERK1/2-Sp3-dependent pathway. 2012 J. Lipid Res. pmid:22693257
Zhang YW et al. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation. 2012 PLoS ONE pmid:22701735
Itoh M et al. Trichostatin A enhances glutamate transporter GLT-1 mRNA levels in C6 glioma cells via neurosteroid-mediated cell differentiation. 2013 J. Mol. Neurosci. pmid:22711563
Kan R et al. Potential role for PADI-mediated histone citrullination in preimplantation development. 2012 BMC Dev. Biol. pmid:22712504
He Q et al. Characterization of an apical ceramide-enriched compartment regulating ciliogenesis. 2012 Mol. Biol. Cell pmid:22718902
Balmer NV et al. Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome. 2012 Hum. Mol. Genet. pmid:22723015
Chen H et al. LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma. 2012 Cancer Lett. pmid:22743615
Zou Y et al. Effect of phenylhexyl isothiocyanate on aberrant histone H3 methylation in primary human acute leukemia. 2012 J Hematol Oncol pmid:22747680
Scholl C et al. Distinct and overlapping gene regulatory networks in BMP- and HDAC-controlled cell fate determination in the embryonic forebrain. 2012 BMC Genomics pmid:22748179
Soleymani Fard S et al. Prostaglandin E2 induces growth inhibition, apoptosis and differentiation in T and B cell-derived acute lymphoblastic leukemia cell lines (CCRF-CEM and Nalm-6). 2012 Prostaglandins Leukot. Essent. Fatty Acids pmid:22749740
Liu S et al. Up-regulation of miR-182 expression after epigenetic modulation of human melanoma cells. 2013 Ann. Surg. Oncol. pmid:22752337
Brose RD et al. Activation of the stress proteome as a mechanism for small molecule therapeutics. 2012 Hum. Mol. Genet. pmid:22752410
Jasek E et al. Effect of histone deacetylase inhibitors trichostatin A and valproic acid on etoposide-induced apoptosis in leukemia cells. 2012 Anticancer Res. pmid:22753739
Gan L et al. Histone deacetylases regulate gonadotropin-releasing hormone I gene expression via modulating Otx2-driven transcriptional activity. 2012 PLoS ONE pmid:22761896
Feng L et al. Histone deacetylase 3 inhibits expression of PUMA in gastric cancer cells. 2013 J. Mol. Med. pmid:22763818
Cogdill AP et al. Targeting the MAGE A3 antigen in pancreatic cancer. 2012 Surgery pmid:22770803
Tong K et al. Schizosaccharomyces pombe Hat1 (Kat1) is associated with Mis16 and is required for telomeric silencing. 2012 Eukaryotic Cell pmid:22771823
Guo X et al. Histone deacetylase inhibitors promote mice corneal allograft survival through alteration of CD4+ effector T cells and induction of Foxp3+ regulatory T cells. 2012 May-Jun Cell. Immunol. pmid:22776176
Zheng L et al. [Detecting acetylated proteins by affinity chromatography column]. 2012 Zhonghua Xue Ye Xue Za Zhi pmid:22781610
Yao J et al. ERK inhibition enhances TSA-induced gastric cancer cell apoptosis via NF-κB-dependent and Notch-independent mechanism. 2012 Life Sci. pmid:22781708
Oh HJ et al. Trichostatin a improves preimplantation development of bovine cloned embryos and alters expression of epigenetic and pluripotency genes in cloned blastocysts. 2012 J. Vet. Med. Sci. pmid:22785124
Sung TY et al. Innovative in vitro chemo-hormonal drug therapy for refractory thyroid carcinomas. 2012 J. Korean Med. Sci. pmid:22787366
Agudelo M et al. Alcohol-induced serotonergic modulation: the role of histone deacetylases. 2012 Alcohol pmid:22796363
Cheng DD et al. Antitumor activity of histone deacetylase inhibitor trichostatin A in osteosarcoma cells. 2012 Asian Pac. J. Cancer Prev. pmid:22799338
Mostovich LA et al. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer. 2012 Epigenetics pmid:22805760
Vadnal J et al. Transcriptional signatures mediated by acetylation overlap with early-stage Alzheimer's disease. 2012 Exp Brain Res pmid:22811216
Lin KT et al. HDAC inhibitors augmented cell migration and metastasis through induction of PKCs leading to identification of low toxicity modalities for combination cancer therapy. 2012 Clin. Cancer Res. pmid:22811583
Kraus J Expression and functions of μ-opioid receptors and cannabinoid receptors type 1 in T lymphocytes. 2012 Ann. N. Y. Acad. Sci. pmid:22823387
Qiao F et al. Enforced expression of RASAL1 suppresses cell proliferation and the transformation ability of gastric cancer cells. 2012 Oncol. Rep. pmid:22825043
Shao G et al. [Effect of monoamine oxidase inhibitor on the differentiation of malignant glioma cell]. 2012 Sheng Wu Yi Xue Gong Cheng Xue Za Zhi pmid:22826952
Balaguer TM et al. Dual regulation of P-glycoprotein expression by trichostatin A in cancer cell lines. 2012 BMC Mol. Biol. pmid:22846052
Colussi C et al. P300/CBP associated factor regulates nitroglycerin-dependent arterial relaxation by N(ε)-lysine acetylation of contractile proteins. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:22859492
Serrat N et al. Deacetylation of C/EBPβ is required for IL-4-induced arginase-1 expression in murine macrophages. 2012 Eur. J. Immunol. pmid:22865229
Yu J et al. Regulation of radiosensitivity by HDAC inhibitor trichostatin A in the human cervical carcinoma cell line Hela. 2012 Eur. J. Gynaecol. Oncol. pmid:22873101
Hu X et al. Histone deacetylase inhibitor trichostatin A promotes the osteogenic differentiation of rat adipose-derived stem cells by altering the epigenetic modifications on Runx2 promoter in a BMP signaling-dependent manner. 2013 Stem Cells Dev. pmid:22873791
Karolczak-Bayatti M et al. Expression of the GTP-binding protein Gαs in human myometrial cells is regulated by ubiquitination and protein degradation: involvement of proteasomal inhibition by trichostatin A. 2012 Reprod Sci pmid:22875848
Joosten M et al. Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotype. 2013 Haematologica pmid:22899583
Zhang C et al. Decreased PADI4 mRNA association with global hypomethylation in hepatocellular carcinoma during HBV exposure. 2013 Cell Biochem. Biophys. pmid:22907585
Conway GD et al. Histone deacetylase activity is required for human oligodendrocyte progenitor differentiation. 2012 Glia pmid:22927334
To SQ et al. Epigenetic mechanisms regulate the prostaglandin E receptor 2 in breast cancer. 2012 J. Steroid Biochem. Mol. Biol. pmid:22929011
Liao V et al. Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects. 2012 Bioorg. Med. Chem. Lett. pmid:22932316
Tigges J et al. Aryl hydrocarbon receptor repressor (AhRR) function revisited: repression of CYP1 activity in human skin fibroblasts is not related to AhRR expression. 2013 J. Invest. Dermatol. pmid:22951721
Shan J et al. ATF4-dependent regulation of the JMJD3 gene during amino acid deprivation can be rescued in Atf4-deficient cells by inhibition of deacetylation. 2012 J. Biol. Chem. pmid:22955275
Sadoul K et al. HDAC6 controls the kinetics of platelet activation. 2012 Blood pmid:22955928
Tomosugi M et al. Retinoblastoma gene-independent G1 phase arrest by flavone, phosphatidylinositol 3-kinase inhibitor, and histone deacetylase inhibitor. 2012 Cancer Sci. pmid:22957647
Miyagawa K et al. Possible involvement of histone acetylation in the development of emotional resistance to stress stimuli in mice. 2012 Behav. Brain Res. pmid:22963996